相关实验视频
Updated: Sep 13, 2025
06:52
Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin
Published on: April 30, 2019
17.7K
里图西马布诱导的肺损伤
Rohit Chari1, Youmna Abdelghany2, Madeleine Purcell1
1University of Maryland School of Medicine, Baltimore, MD, USA.
BMC pulmonary medicine
|July 29, 2025
概括
与利图西马布相关的间歇性肺病 (RTX-ILD) 是淋巴瘤治疗的一个罕见但严重的并发症. 长时间服用类固醇可以帮助管理RTX-ILD,使患者能够完成必要的R-CHOP化疗.
科学领域:
- 在瘤学瘤学.
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 利图西马布是一种单克隆抗体,用于治疗像DLBCL这样的B细胞淋巴瘤.
- 与rituximab相关的间歇性肺病 (RTX-ILD) 是一种新出现的并发症.
- 非传染性肺毒性需要在瑞图西马布治疗期间保持警.
研究的目的:
- 在接受R-CHOP治疗的患者中报告RTX-ILD病例.
- 讨论RTX-ILD的管理,当rituximab对于治疗意图至关重要时.
- 要突出长期使用类固醇在管理RTX-ILD中的作用.
主要方法:
- 一名患有DLBCL的73岁女性接受了R-CHOP化疗.
- 患者在里图西马布输注后出现了急性呼吸道症状和低氧症.
- 诊断工作包括成像和支气管镜检查;治疗涉及类固醇和修改的R-CHOP计划.
主要成果:
- 在Rituximab输注后,患者出现了呼吸短促和低氧化症.
- 胸部成像显示了分散的地面玻璃不透明度.
- 类固醇治疗导致了转基因生物的解决和改善氧化,使R-CHOP.完成.
结论:
- RTX-ILD是一种罕见但严重的并发症,需要高度怀疑才能诊断.
- 通常建议停止治疗rituximab,但如果有治愈的意图,长期的类固醇治疗可能允许继续治疗.
- 与类固醇联合治疗可以帮助在DLBCL的R-CHOP治疗期间保持肺功能.
相关概念视频
01:17Pulmonary Cycle: Exhalation
1.8K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.8K
01:27Pneumothorax-II
366
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
366